Allan T Bombard MD

PubMed

• 1 citations
  Performance of a Multianalyte 'Rule-Out' Assay in Pregnant Individuals With Suspected Preeclampsia.
  Maged M Costantine, Baha Sibai, Allan T Bombard, Mark Sarno, Holly West
  Hypertension. 2022-07-01
• 5 citations
  Evaluation of a novel screening method for fetal aneuploidy using cell-free DNA in maternal plasma.
  Richard P. Porreco, Matthew Sekedat, Allan T. Bombard, Thomas J. Garite, Kimberly Maurel
  Journal of Medical Screening. 2020-03-01
• 14 citations
  Application of risk score analysis to low-coverage whole genome sequencing data for the noninvasive detection of trisomy 21, trisomy 18, and trisomy 13.
  John A. Tynan, Sung Kyun Kim, Amin Mazloom, Chen Zhao, Graham McLennan
  Prenatal Diagnosis. 2016-01-01

Journal Articles

• Circulating cell free DNA testing: are some test failures informative?  
  Palomaki GE, Kloza EM, Lambert-Messerlian GM, van den Boom D, Ehrich M, Deciu C, Bombard AT, Haddow JE, Prenat Diagn, 1/8/2015
• Factors affecting levels of circulating cell-free DNA in maternal plasma and their implications for noninvasive prenatal testing  
  Kinnings S, Geis J, Almasri E, Wang T, Guan X, McCullough R, Bombard A, Saldivar J-S, Oeth P, Deciu C, Prenat Diagn, 1/1/2015
• Noninvasive prenatal testing for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing ...  
  Porreco RP, Garite TJ, Maurel K, Maruziak B, Ehrich M, van den Boom D, Deciu C, Bombard A, Am J Obstet Gynecol, 1/1/2014

Books/Book Chapters

• Clin Obstet Gynecol 
  Chapter: Noninvasive prenatal detection of aneuploidy. 
  Page 210 - 225Robinson C, van den Boom D, Bombard AEditors: Scott, JR MD and Gabbe SG, Skupski, D MD (Guest Ed.).Wolters Kluwer/Lippincott Williams & Wilkins Publishers, Philadelphia, PA2014
• Clin Lab Med 
  Chapter: Prenatal Screening for Open Fetal Defects. 
  Page 385 - 394Canick J, Kellner LH and Bombard ATW. B. Saunders, Inc., Philadelphia, PA2003
• Complications of Pregnancy 
  Chapter: Teratogenic Drugs. 
  Ferreira JCP, Sachs GS, Bombard ATEditors: Parisi V and Cohen WR.JB Lippincott Company, Philadelphia, PAEdition 5th,1999

Abstracts/Posters

• Whole-genome maternal plasma DNA sequencing for fetal aneuploidy accurately detects autosomal and sex chromosome abnormalities: An Internal Validation Study with Indep...
  Tarrier B, Mann T, Kim J, Clos L, Sekedat M, Stoerker J, Bombard A, International Society of Prenatal Diagnosis Annual Meeting, Washington, DC, 1/1/2015
• A case of maternal malignancy diagnosed following a quadruple aneuploidy NIPT result.
  Settler C, Dohany L, Manthei E, Chaperon J, Bombard A, American College of Medical Genetics Annual Meeting, Salt Lake City, UT, 1/1/2015
• Implementation of pharmacogenetic testing for anti-depressant and anti-psychotic medication into the Obstetrician/Gynecologist practice.
  Dohany L, Stoerker J, DaRae J, Chaperon J, Settler C, Bombard A, Buis J, American College of Medical Genetics Annual Meeting, Salt Lake City, UT, 1/1/2015

Lectures

• Noninvasive prenatal diagnosis-Closing the Gaps: Are we ready to accept NIPT in clinical practice. 
  Istanbul, Turkey - 1/1/2013
• Circulating Cell-Free (ccf) Nucleic Acid Technology: The Evolution of Prenatal Diagnosis. 
  Honolulu, HI - 1/1/2013
• Transitioning New Technologies from the Bench to the Bedside: Direct Fetal Testing Using Circulating Cell-Free DNA. 
  San Francisco, CA - 1/1/2013

Other

• Ob Team Stat: Rapid response to obstetrical emergencies. 
  Clements CJ, Flohr-Rincon S, Bombard AT, Catanzarite V, Nursing for Women's Health (AWHONN)
  1/1/2007
• Indications for use: Prenatal Diagnosis 
  Bombard AT, Determining the utility of clinical tests-NCCLS Guideline
  1/1/2004
• Privacy and Preventive Health Care: Integrating Coverage of Genetic Technologies into Health Care Policies. 
  Bombard A, Cohen AW, Harvard Health Caucus: Working Paper Series, The Social Implications of the Human Genome Project
  http://web.med.harvard.edu/healthcaucus/
  1/1/2002